Profound lesions resulting in the death of parenchymal cells and inflammation instigate reactive astrogliosis that forms a border between damaged non-neural lesion core and surrounding neural tissue
On March 9, Hims & Hers said in a press release that it plans to phase out compounded semaglutide and transition patients to injectable Ozempic or Wegovy or the new oral Wegovy, though compounded medications were still listed on its website as of midday
It is known that chronic cerebral hypoperfusion is a key pathogenetic factor of neurocognitive disorders
Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and associations with progression to end-stage renal disease and mortality
Production of xylooligosaccharides from garlic straw xylan by purified xylanase from Bacillus mojavensis UEB-FK and their in vitro evaluation as prebiotics
DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030 USD 1034.78 BN MARKET SIZE, 2030 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The injectable drug delivery market is projected to reach USD 1,034.78 billion by 2030 from USD 690.23 billion in 2025, at a CAGR of 8.4% from 2025 to 2030
